EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
How EY can help
-
EY Government Contract Services provides government contracting consulting, government contract accounting and pharmaceutical government pricing support.
Read more
Ensuring compliance with the constantly expanding and evolving regulatory environment surrounding participation in government programs is a daunting task. Many US pharmaceutical drug manufacturers are turning to GP MSOs to curb costs and mitigate risks. Price reporting requirements can be onerous — complex pricing methodologies; high volumes of data; and for some manufacturers, unsystematic, inconsistent and nonstructured data — making it challenging to consistently generate compliant government prices. Due to continual focus on meeting short submission deadlines, processing difficulties and dwindling resources, manufacturers continue to be challenged with devoting enough time to effectively analyze GP calculation results before submissions are due. Manufacturers recognize that there is a sensible alternative to develop and maintain highly specialized systems and operators in house, and partnering with trusted providers is an obvious choice for some. While it has been more common for emerging and smaller pharmaceutical companies to enlist MSOs to manage various GP recurring operations, mid- to large-cap pharmaceutical manufacturers are now seeking more efficient solutions and recognizing the significant advantages of turning to an MSO for specific aspects of their revenue management technology and operations to qualified MSOs. For large pharmaceutical manufacturers with diverse portfolios and complex operations, engaging qualified MSOs translates into streamlined processes, better risk management and improved overall operational efficiency.